$4.86 +0.06 (%) Array Biopharma Inc - NASDAQ

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Mid-Day Market Update: Hawaiian Electric Climbs On Merger News; Barnes & Noble Shares Slide

    Benzinga | Dec. 4, 2014 | 12:39PM EST
  2. Mid-Morning Market Update: Markets Mostly Lower; Dollar General Posts Downbeat Earnings

    Benzinga | Dec. 4, 2014 | 10:35AM EST
  3. Morning Market Movers

    Benzinga | Dec. 4, 2014 | 09:41AM EST
  4. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 4, 2014 | 08:13AM EST
  5. UPDATE: Array To Regain Worldwide Rights To Binimetinib

    Benzinga | Dec. 3, 2014 | 16:03PM EST
  6. Markets Tumble; SodaStream Issues Downbeat Revenue Forecast

    Benzinga | Oct. 7, 2014 | 11:17AM EST
  7. Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer

    Benzinga | Sep. 12, 2014 | 14:00PM EST
  8. Earnings Scheduled For August 12, 2014

    Benzinga | Aug. 12, 2014 | 05:16AM EST
  9. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout Target

    Benzinga | Jul. 23, 2014 | 15:46PM EST
  10. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga | Jul. 23, 2014 | 14:19PM EST
  11. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga | Jul. 23, 2014 | 11:19AM EST
  12. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 10:48AM EST
  13. Array Biopharma Announces Binimetinib Continues to Advance in Clinical Development

    Benzinga | Apr. 23, 2014 | 13:24PM EST
  14. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 4, 2014 | 08:29AM EST
  15. Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

    Benzinga | Mar. 3, 2014 | 10:27AM EST
  16. Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with TDM-1 in Patients with Metastatic HER2+ Breast Cancer

    Benzinga | Feb. 20, 2014 | 08:09AM EST
  17. Array BioPharma Issues Update on ARRY-614 for Myelodysplastic Syndromes at '13 ASHM

    Benzinga | Dec. 9, 2013 | 12:00PM EST
  18. Array BioPharma Issues Update on ARRY-520 for Multiple Myeloma at '13 ASHM

    Benzinga | Dec. 9, 2013 | 08:32AM EST
  19. Pharmaceutical Industry Expected To Collect Billions From Obamacare

    Benzinga | Oct. 2, 2013 | 12:51PM EST
  20. These ETFs House The Next Biotech Takeover Targets

    Benzinga | Aug. 26, 2013 | 07:44AM EST
  21. Benzinga's Top Pre-Market Losers

    Benzinga | Aug. 9, 2013 | 08:19AM EST
  22. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting

    Benzinga | Dec. 10, 2012 | 09:01AM EST
  23. John Orwin Joins Array BioPharma Board Of Directors

    Benzinga | Nov. 7, 2012 | 01:51AM EST
  24. Array BioPharma Inc. Reports Operating Results (10-Q)

    GuruFocus | Oct. 30, 2012 | 09:03AM EST
  25. Array BioPharma CEO Favors Open, Unbiased Questions

    IBD | Oct. 12, 2012 | 10:29AM EST
  26. Singles Only: 3 Low-Priced Stocks for Your Portfolio

    SchaeffersResearch | Oct. 11, 2012 | 12:14PM EST
  27. Array Announces Changes to Board

    Benzinga | Aug. 31, 2012 | 10:01AM EST
  28. Array BioPharma Inc. Reports Operating Results (10-K)

    GuruFocus | Aug. 16, 2012 | 12:21PM EST
  29. Polypore International, True Religion Apparel Among Stocks Gapping Down Wednesday

    FoxBusiness | Aug. 1, 2012 | 04:31AM EST
  30. Health Care Sector Wrap

    FoxBusiness | Jul. 23, 2012 | 10:47AM EST
  31. Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes Collaboration

    Benzinga | Jul. 19, 2012 | 02:32AM EST
  32. Clovis Oncology and Array BioPharma Announce Agreement to Discover Novel Mutant KIT Inhibitor

    Benzinga | Jul. 16, 2012 | 10:31AM EST
  33. MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial

    Benzinga | Jun. 4, 2012 | 10:51AM EST
  34. Highs & Lows: Array BioPharma, NII Holdings, and MEMC Electronic Materials

    SchaeffersResearch | May. 17, 2012 | 14:54PM EST
  35. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,545 Shares

    GuruFocus | Feb. 10, 2012 | 11:37AM EST
  36. Array BioPharma Announces Proposed Public Offering of 20M Shares

    Benzinga | Feb. 9, 2012 | 02:00AM EST
  37. Benzinga's Top Pre-Market Losers

    Benzinga | Feb. 9, 2012 | 01:15AM EST
  38. Array BioPharma Inc. Reports Operating Results (10-Q)

    GuruFocus | Feb. 2, 2012 | 00:54AM EST
  39. Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors

    Benzinga | Jan. 30, 2012 | 09:36AM EST
  40. From Earlier: Array BioPharma's Chief Executive Officer Robert E. Conway Resigns

    Benzinga | Jan. 17, 2012 | 00:20AM EST
  41. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,994 Shares

    GuruFocus | Jan. 12, 2012 | 12:43PM EST
  42. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,743 Shares

    GuruFocus | Dec. 12, 2011 | 11:47AM EST
Trading Center